
| Pair Name | Chlorogenic acid, Doxorubicin | ||
| Phytochemical Name | Chlorogenic acid (PubChem CID: 1794427 ) | ||
| Anticancer drug Name | Doxorubicin (PubChem CID: 31703 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Chlorogenic acid, Doxorubicin | |||
| Disease Info | [ICD-11: 2B51] | Osteosarcoma | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Down-regulation | Phosphorylation | MAPK1 | hsa5594 |
| Down-regulation | Phosphorylation | MAPK3 | hsa5595 | |
| Up-regulation | Cleavage | CASP3 | hsa836 | |
| Up-regulation | Cleavage | PARP1 | hsa142 | |
| In Vitro Model | U2OS | Osteosarcoma | Homo sapiens (Human) | CVCL_0042 |
| MG-63 | Osteosarcoma | Homo sapiens (Human) | CVCL_0426 | |
| Result | These findings firstly propose CGA as a promising chemosensitizer and cardioprotective agent in OS therapy, suggesting the p44/42 MAPK pathway as relevantly involved in CGA-mediated Doxo susceptibility. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells. Int J Mol Sci. 2021 Aug 10;22(16):8586. doi: 10.3390/ijms22168586. | Click |